Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma von O'CONNOR, Owen A, WRIGHT, John, DUMETRESCU, Otila, ESSELTINE, Dixie, TREHU, Elizabeth, ADAMS, Julian, SCHENKEIN, David, ZELENETZ, Andrew D, MOSKOWITZ, Craig, MUZZY, Jamie, MACGREGOR-CORTELLI, Barbara, STUBBLEFIELD, Michael, STRAUS, David, PORTLOCK, Carol, HAMLIN, Paul, CHOI, Elizabeth

Volltext